Editorial: Viral infection, tumor development and host immune response.

Li, Xin; An, Liwei; Jin, Yucui; Gui, Jun; Lin, Weitao; Wen, Zhenke; Kassab, Muzaffer Ahmad; Chen, Jie

Li, Xin; An, Liwei; Jin, Yucui; Gui, Jun; Lin, Weitao; Wen, Zhenke; Kassab, Muzaffer Ahmad; Chen, Jie.

Afiliação

Li X; Chinese Academy of Sciences (CAS) Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.
An L; Department of Stomatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Jin Y; Department of Biochemistry and Molecular Biology, Tongji University School of Medicine, Shanghai, China.
Gui J; Department of Medical Genetics, Nanjing Medical University, Nanjing, China.
Lin W; State Key Laboratory of Oncogenes and Related Genes, Med-X Clinical Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wen Z; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.
Kassab MA; Centre for Precision Health, Edith Cowan University, Joondalup, WA, Australia.
Chen J; Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.

Front Cell Infect Microbiol ; 13: 1177032, 2023.

Article em En | MEDLINE | ID: mdl-36968104

Assuntos

Neoplasias; Viroses; Humanos; Imunidade Inata

Palavras-chave

cancer; immune response; inflammation; precise prevention and precise treatment; viral infection

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Viroses / Neoplasias Limite: Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google